Mounjaro and Zepbound are now out of shortage. This should be good news—but because so many patients are taking compounded versions of these GLP-1 medications, it’s a complicated situation.
https://www.wired.com/story/glp-1-shortage-mounjaro-zepbound-tirzepatide-compounded/